S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.
about
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential RisksSphingosine kinase 1/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertensionThe clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in ratMammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertensionCFTR and sphingolipids mediate hypoxic pulmonary vasoconstrictionThe Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery HypertensionThe role of hypoxia in pulmonary vascular diseases: a perspective.Targeting sphingosine-1-phosphate signaling in lung diseases.Sphingosine-1-phosphate is involved in the occlusive arteriopathy of pulmonary arterial hypertension.Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatmentPulmonary vascular dysfunction secondary to pulmonary arterial hypertension: Insights gained through retrograde perfusion.The endothelium in hypoxic pulmonary vasoconstriction.
P2860
Q26738344-77E3A756-F340-4FED-B215-EFF4150D64D2Q26778497-4BC5113A-A57A-403C-9A44-E3F9900311BBQ28484640-2C26CB55-1622-408D-96D4-FDCEF742A00BQ33829692-D6F73FB5-F720-4885-9803-0E9F3E41A472Q33974580-6A8EF98B-2934-4273-BC39-D40ABB339C75Q34025135-ED9001DC-B893-4487-81FF-B6FCB74A8CD9Q34364844-0BBD9AD5-AC70-4CDB-983F-A197B4894EC7Q34986940-ADD4F431-0400-4D87-B401-09BD5F1547D8Q35279508-8F4C4DFD-8DAA-4639-8F97-3D82CB223C13Q35844410-7208E750-8808-408C-8FD2-F32B62AAA2CEQ38078782-40092B26-8390-4B45-8F09-C670385BAC82Q38952840-24A70A5E-B3EE-4BCE-A654-2F6FDD002351Q41065352-9A6E17CA-A7F4-4C59-BF95-E02271CD2CD3Q42366660-79338E8B-1588-4EF2-807F-7B42DEB76410Q49975721-AB5283F5-6FBB-492C-9F09-152FEDB3F114Q50241212-100A0F65-C666-44AC-B972-9C356FE50E51
P2860
S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
S1P(4) receptor mediates S1P-i ...... ve and hypertensive rat lungs.
@en
type
label
S1P(4) receptor mediates S1P-i ...... ve and hypertensive rat lungs.
@en
prefLabel
S1P(4) receptor mediates S1P-i ...... ve and hypertensive rat lungs.
@en
P2093
P2860
P356
P1476
S1P(4) receptor mediates S1P-i ...... ve and hypertensive rat lungs.
@en
P2093
Hiroki Ota
Ivan F McMurtry
Kohtaro Abe
Masahiko Oka
Masako Ito
Michelle A Beutz
P2860
P304
P356
10.4103/2045-8932.87309
P577
2011-07-01T00:00:00Z